Fox News Airs Morphed Photo Of Trump Search Warrant Judge With Ghislaine Maxwell
Fox News has been slammed for sharing a doctored photo of the federal judge who signed off on the recent FBI search of former President Donald Trump’s Mar-a-Lago property. In the news clip, Fox News aired a photo that replaced an old image of Jeffrey Epstein getting a foot massage from Ghislaine Maxwell with the body and […]
Elon Musk Posts ‘Sex Tape’ Online: ‘Best. Clickbait. Ever.’
Tesla Inc (NASDAQ: TSLA) CEO Elon Musk has taken Twitter by storm by sharing his “sex tape” tweet, sending his fans wild guesses. What Happened: Musk shared an image that he labeled as his “sex tape,” showing two tape dispensers placed in a way that formed the number 69. Then he joked in the caption, saying, […]
Catalent-Repligen Merger ‘Seems Unlikely,’ This Analyst Says
Yesterday, Catalent Inc (NYSE: CTLT) announced to acquire Metrics Contract Services for $475 million. Keybanc notes that the deal strengthens CTLT’s oral delivery portfolio and targets rapidly growing biologic applications. Metrics produces highly active pharmaceutical ingredients that are very difficult to produce but very potent in small doses. “After recent acquisitions and capacity expansion on the cell and gene […]
HSBC’s Largest Shareholder Stresses On Asia Business Spinoff To Boost Market Values: Report
HSBC Holdings Plc’s (NYSE: HSBC) top shareholder, Ping An Insurance Group Co, isn’t convinced by pushback on HSBC’s spinoff of its Asia operations. The shareholder argues that HSBC requires urgent and radical change, Bloomberg reported citing a person familiar with its views. The report says that Ping An estimates the spinoff would generate an additional market value of $25-$35 […]
Oregon Psilocybin Services Act: State Vs. Local Decisions, The Ultimate ‘Opt-Out’ Choice
Oregon’s elected councilors in Philomath joined the debate on whether to offer their voters to “opt out” of Measure 109, the state-wide legalization project for the use of medical psilocybin. The legislation is set to begin ruling as of January 2023 and would make Oregon the first state to allow lawful psilocybin use, under specific conditions. […]
Have We Seen The Beginning Of The End Of Data Privacy In The European Union?
With the goal of protecting the European Union (EU) from child pornographers and other unsavory and illegal activity, the Digital Services Act, a regulatory act aimed at making the internet a safer place, is on its way to cracking down on Big Tech. Big Tech Could Be Facing Big Fines If Companies Don’t Comply Beginning […]
TC BioPharm Says It Aims To Deliver A Big Breakthrough In Cancer Treatments
Approximately 1.7 million new cancer cases are reported every year in the United States. As the nation’s second leading cause of death after heart disease, there are around 600,000 cancer-related deaths each year. While those numbers look grim, medical breakthroughs in the past decades have made a huge impact, bringing mortality rates down 27% from […]
Learn About Latest Petition To Reschedule Magic Mushrooms In The UK
A new public appeal, launched just days ago, aims at moving psilocybin from Schedule 1 to Schedule 2 of UK’s Misuse of Drugs 2001 legislation. As all regulations, it determines the legal circumstances for possession, supply, production, export and import of the listed (so called “controlled”) drugs. The authorized scope depends on the assigned schedule, ranging […]
Pfizer, Global Blood Therapeutics In Advanced Talks For $5B Buyout Deal: Report
Pfizer Inc (NYSE: PFE) is reportedly in advanced talks to buy Global Blood Therapeutics Inc (NASDAQ: GBT) for about $5 billion, bolster its portfolio and pipeline. Global Blood Therapeutics markets sickle-cell disease treatment, Oxbryta, which generated $194.7 million in revenue in 2021. Read More
India Based Pharma Companies In Race To Buy Athenex, Shares Surge
Athenex Inc (NASDAQ: ATNX) shares climbed during the after-hours session as India’s Intas Pharmaceuticals and Dr Reddy’s Laboratories Ltd (NYSE: RDY) are reportedly in talks to acquire Athenex. According to the Economic Times report, the deal could be valued at $200-250 million as the U.S.-based biotechnology firm looks to sell a controlling stake. The two Indian pharma companies are competing with […]